Unilife Corporation

Unilife is a U.S-based medical device and technology company that designs, develops, manufactures and supplies innovative, differentiated delivery systems for injectable drugs, biologics and vaccines. Unilife has a broad portfolio of injectable drug delivery systems including prefilled syringes, auto-injectors, wearable injectors, drug reconstitution delivery systems, ocular delivery systems and novel devices. Unilife builds long-term partnerships with pharmaceutical and biotechnology companies seeking to leverage our products to enable, enhance and differentiate their injectable therapies. Unilife can develop or customize its device technologies to address the specific drug, commercial and patient needs of its pharmaceutical customers. Unilife’s dynamic business environment, advanced operational capabilities, world-class team and stringent quality processes enables the Company to serve the device innovation needs of its pharmaceutical customers with speed, agility and reliability. A state-of-the-art global headquarters and manufacturing facility in York, PA serves as an integrated center for the seamless design, development, production, quality control, regulatory compliance and commercial supply of its products.

Company Growth (employees)
Type
Public
HQ
York, US
Founded
2002
Size (employees)
160 (est)-30%
Unilife Corporation was founded in 2002 and is headquartered in York, US

Key People at Unilife Corporation

Alan D. Shortall

Alan D. Shortall

CEO
Ramin Mojdehbakhsh

Ramin Mojdehbakhsh

COO

Unilife Corporation Office Locations

Unilife Corporation has offices in York and King of Prussia
York, US (HQ)
250 Cross Farm Lane
King of Prussia, US
150 S Warner Rd

Unilife Corporation Data and Metrics

Unilife Corporation Financial Metrics

Unilife Corporation's revenue was reported to be $14.8 m in FY, 2016
USD

Revenue (FY, 2016)

14.8 m

Revenue growth (FY, 2015 - FY, 2016), %

13%

Net income (FY, 2016)

(100.8 m)

EBIT (FY, 2016)

(103.6 m)

Market capitalization (20-Apr-2017)

2.7 m

Closing share price (20-Apr-2017)

0.2

Cash (31-Dec-2016)

18.7 m

EV

(15.4 m)
Unilife Corporation's current market capitalization is $2.7 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

14.7 m13.2 m14.8 m

Revenue growth, %

(10%)13%

R&D expense

34.1 m52.5 m43.2 m

General and administrative expense

27.9 m36.2 m43.2 m

Operating expense total

66.1 m93.6 m118.5 m

EBIT

(51.4 m)(80.4 m)(103.6 m)

EBIT margin, %

(350%)(611%)(698%)

Interest expense

7.3 m6.4 m10.2 m

Net Income

(57.9 m)(90.8 m)(100.8 m)
USDQ3, 2014Q1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016

Revenue

1.4 m1.4 m5.4 m2.9 m3.2 m4.5 m822 k1.7 m2.3 m

R&D expense

8 m11 m11.3 m13.2 m16 m10.5 m9.3 m6.8 m5.7 m

General and administrative expense

6.6 m8.2 m9.5 m9.1 m9.2 m8.8 m17.6 m8.2 m6.1 m

Operating expense total

14.7 m19.2 m20.8 m22.3 m25.2 m19.3 m26.9 m15 m11.8 m

EBIT

(14.3 m)(18.9 m)(16.7 m)(20.5 m)(23.6 m)(16.2 m)(54.2 m)(15 m)(10.4 m)

EBIT margin, %

(1035%)(1369%)(308%)(703%)(740%)(361%)(6593%)(873%)(446%)

Interest expense

809 k1.1 m1.8 m1.8 m1.7 m1.9 m2.7 m4.3 m4.5 m

Interest income

(6 k)

Net Income

(42.6 m)(22.3 m)(41.6 m)(64.8 m)(25.9 m)(51.3 m)(93.1 m)(18 m)(33.3 m)
USDFY, 2014FY, 2015FY, 2016

Cash

8.4 m12.3 m18.7 m

Accounts Receivable

1.9 m1.5 m374 k

Inventories

142 k151 k89 k

Current Assets

13.9 m17 m23.2 m

PP&E

54.6 m66.1 m54.8 m

Goodwill

11.8 m9.7 m9.4 m

Total Assets

81.8 m94.1 m87.7 m

Accounts Payable

3.6 m4 m2.7 m

Total Debt

669 k

Current Liabilities

8.3 m14.8 m18.7 m

Total Liabilities

174.4 m

Additional Paid-in Capital

296.2 m364.8 m398.9 m

Retained Earnings

(293.7 m)(384.6 m)(485.4 m)

Total Equity

6.1 m(17.9 m)(86.7 m)

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

13.3 x-5.3 x-1 x
USDQ3, 2014Q1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016

Cash

37.7 m4.2 m8.4 m37.1 m5.8 m18 m41.6 m6 m9.3 m

Accounts Receivable

1.6 m4.6 m4.2 m5.9 m1.4 m3 m218 k2.1 m2.9 m

Inventories

63 k147 k165 k137 k107 k122 k110 k88 k100 k

Current Assets

42 m12 m16.2 m46.2 m10.6 m25.9 m46.9 m11.3 m21.3 m

PP&E

46.7 m56.4 m58.6 m62 m79.1 m81.8 m55.1 m53.3 m52.3 m

Goodwill

11.6 m11 m10.3 m9.7 m8.9 m9.2 m9.7 m9.7 m9.1 m

Total Assets

101.8 m80.7 m86.4 m119.3 m99.8 m118.2 m112 m74.5 m83 m

Accounts Payable

3.3 m6.2 m5.8 m4.4 m9.1 m10.7 m4.4 m3.5 m2.6 m

Current Liabilities

8.5 m11.5 m13.8 m16.8 m33.3 m39.3 m29.7 m20 m24.4 m

Additional Paid-in Capital

294.7 m310.4 m313.2 m360.8 m377.7 m385 m397.5 m399.9 m401.1 m

Retained Earnings

(278.5 m)(316 m)(335.4 m)(358.5 m)(410.4 m)(435.9 m)(477.6 m)(503.3 m)(518.6 m)

Total Equity

19.8 m4.2 m(31.7 m)(49.2 m)

Financial Leverage

5.2 x28.2 x-3.2 x-2.4 x
USDFY, 2014FY, 2015FY, 2016

Net Income

(57.9 m)(90.8 m)(100.8 m)

Depreciation and Amortization

4.1 m4.9 m5.5 m

Accounts Receivable

(266 k)330 k757 k

Inventories

(71 k)(9 k)62 k

Accounts Payable

1.1 m431 k(1.2 m)

Cash From Operating Activities

(36.6 m)(55.2 m)(28.4 m)

Purchases of PP&E

(12.1 m)(16.6 m)(17.3 m)

Cash From Investing Activities

(12.1 m)(16.6 m)(17.3 m)

Cash From Financing Activities

51.3 m75.8 m52.2 m

Interest Paid

3.2 m6.5 m4.2 m
USDQ3, 2014Q1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016

Net Income

(42.6 m)(22.3 m)(41.6 m)(64.8 m)(25.9 m)(51.3 m)(93.1 m)(18 m)(33.3 m)

Depreciation and Amortization

3.1 m1.1 m2.4 m3.5 m1.5 m3 m4.5 m1.7 m2.7 m

Accounts Receivable

137 k(288 k)(2.3 m)203 k168 k(797 k)913 k(1.7 m)(2.5 m)

Inventories

8 k(5 k)(23 k)5 k44 k29 k41 k1 k(11 k)

Accounts Payable

781 k2.6 m2.2 m843 k4.9 m6.7 m555 k880 k7 k

Cash From Operating Activities

(13 m)(13.1 m)(25 m)(36.2 m)(13.6 m)(13.7 m)(12.9 m)(12.5 m)(23.3 m)

Purchases of PP&E

(3.4 m)(3.6 m)(6.9 m)(11.5 m)(2.8 m)(6.8 m)(10.6 m)(363 k)(482 k)

Cash From Investing Activities

(3.4 m)(3.6 m)(6.9 m)(11.5 m)(2.8 m)(6.8 m)(10.6 m)(363 k)(482 k)

Cash From Financing Activities

48.2 m12.6 m32 m76.5 m9.9 m26.1 m52.8 m141 k14.4 m

Interest Paid

1.8 m2.1 m4 m218 k432 k
Y, 2016

EV/EBIT

0.1 x

EV/CFO

0.7 x

Financial Leverage

-1 x

Unilife Corporation Operating Metrics

FY, 2016

Patents Issued

280

Unilife Corporation Market Value History

Unilife Corporation Revenue Breakdown

Unilife Corporation Job Categories

Traffic Overview of Unilife Corporation

Unilife Corporation Online and Social Media Presence

Unilife Corporation Company Life and Culture

You may also be interested in